Evoke Wealth LLC Has $12.82 Million Stake in Doximity, Inc. (NASDAQ:DOCS)

Evoke Wealth LLC decreased its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 11.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 240,034 shares of the company's stock after selling 31,052 shares during the quarter. Evoke Wealth LLC owned approximately 0.13% of Doximity worth $12,815,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Thrivent Financial for Lutherans increased its stake in shares of Doximity by 31.0% in the 4th quarter. Thrivent Financial for Lutherans now owns 40,609 shares of the company's stock valued at $2,169,000 after buying an additional 9,618 shares during the period. Counterpoint Mutual Funds LLC acquired a new stake in shares of Doximity during the fourth quarter worth $1,820,000. Corient Private Wealth LLC grew its stake in shares of Doximity by 3.9% during the fourth quarter. Corient Private Wealth LLC now owns 8,887 shares of the company's stock worth $474,000 after purchasing an additional 334 shares during the period. one8zero8 LLC acquired a new stake in shares of Doximity during the fourth quarter worth $267,000. Finally, Natixis Advisors LLC grew its stake in shares of Doximity by 12.8% during the fourth quarter. Natixis Advisors LLC now owns 35,882 shares of the company's stock worth $1,916,000 after purchasing an additional 4,067 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 37.40% of the stock is currently owned by corporate insiders.

Remove Ads

Doximity Trading Up 0.4 %

Shares of Doximity stock traded up $0.24 during trading on Friday, reaching $63.01. The stock had a trading volume of 4,032,344 shares, compared to its average volume of 1,880,305. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The company has a market capitalization of $11.76 billion, a price-to-earnings ratio of 63.01, a P/E/G ratio of 4.10 and a beta of 1.34. The stock has a fifty day moving average price of $64.42 and a two-hundred day moving average price of $53.39.

Analyst Upgrades and Downgrades

DOCS has been the subject of a number of analyst reports. Canaccord Genuity Group lifted their price objective on Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research note on Friday, February 7th. Mizuho lifted their price objective on Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. KeyCorp decreased their price objective on Doximity from $70.00 to $65.00 and set an "overweight" rating for the company in a research note on Wednesday, January 8th. Leerink Partnrs raised Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Finally, Wells Fargo & Company reissued an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.